Cue Biopharma, Inc. Common Stock (CUE)
Across 7 earnings reports since May 09, 2024, Cue Biopharma, Inc. Common Stock (CUE) has a clear post-earnings pattern. It moves ±9.67% on average after reporting and finishes higher 0.0% of the time. Its largest post-earnings gain was -0.54% (May 12, 2025) and its largest decline was -17.55% (Nov 14, 2024).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
7
Avg Abs. Movement
±9.67%
Positive %
0.0%
Negative %
100.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | ☽ POST | $0.31 | $0.32 | $0.31 | 12,004 | -15.99% | open_in_new |
| Nov 12, 2025 | ☽ POST | $0.67 | $0.67 | $0.65 | 405 | -7.17% | open_in_new |
| Aug 12, 2025 | ☽ POST | $0.81 | $0.81 | $0.80 | 1,279 | -0.91% | open_in_new |
| May 12, 2025 | ☽ POST | $0.78 | $0.78 | $0.76 | 6,039 | -0.54% | open_in_new |
| Mar 31, 2025 | ☽ POST | $0.90 | $0.90 | $0.90 | 2,757 | -16.66% | open_in_new |
| Nov 14, 2024 | ☽ POST | $1.49 | $1.56 | $1.51 | 30,100 | -17.55% | open_in_new |
| May 09, 2024 | ☽ POST | $1.92 | $1.96 | $1.92 | 9,834 | -8.88% | open_in_new |
Earnings Count
7
Total earnings in dataset
Avg Abs. Movement
±9.67%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 3 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 8-K | 20260603 | open_in_new SEC.gov |
| S-3 | 20260603 | open_in_new SEC.gov |
| S-8 | 20260603 | open_in_new SEC.gov |
| 3 | 20260602 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| 8-K | 20260602 | open_in_new SEC.gov |
| DEF 14A | 20260521 | open_in_new SEC.gov |
Frequently asked about CUE earnings
How much does CUE stock move after earnings? expand_more
Over 7 reports, CUE has moved an average of ±9.67% the session after earnings, closing higher 0.0% of the time.
What was CUE's biggest post-earnings move? expand_more
CUE's largest post-earnings gain on record was -0.54% on May 12, 2025, and its largest decline was -17.55% on Nov 14, 2024.
Where can I find Cue Biopharma, Inc. Common Stock's SEC filings? expand_more
All of Cue Biopharma, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right